Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Recombinant Proteins
  4. 286EP250

R&D Systems™ Recombinant Human Erythropoietin/EPO (Ultrapure) Protein, CF

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

Supplier:  R&D Systems™ 286EP250

Catalog No. 286EP250

Item Discontinued This item has been discontinued by the manufacturer and is no longer available. Please reach out to your sales representative.

This item is not returnable. View return policy

Description

Description

The Recombinant Human Erythropoietin (Ultrapure) Protein is derived from CHO. The Recombinant Human Erythropoietin (Ultrapure) Protein has been validated for the following applications: Bioactivity.
Specifications

Specifications

P01588
2056
Erythropoietin/EPO
Chinese Hamster Ovary cell line, CHO-derived human Erythropoietin/EPO protein
ECYT5, EP, EPO, epoetin, erythropoietin, MGC138142, MVCD2
Recombinant
Supplied as a 0.2μm filtered solution in PBS.
21 kDa
250U
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after opening. 3 months, -20 to -70° C under sterile conditions after opening.
Unconjugated
97%, by SDS-PAGE under reducing conditions and visualized by silver stain.
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit